Centene (CNC) – Investment Analysts’ Recent Ratings Updates

Centene (NYSE: CNC) has recently received a number of price target changes and ratings updates:

• 11/4/2024 – Centene had its price target lowered by analysts at Wells Fargo & Company from $91.00 to $90.00. They now have an “overweight” rating on the stock.
• 10/30/2024 – Centene had its price target lowered by analysts at Sanford C. Bernstein from $96.00 to $88.00. They now have an “outperform” rating on the stock.
• 10/29/2024 – Centene had its price target lowered by analysts at Barclays PLC from $97.00 to $91.00. They now have an “overweight” rating on the stock.
• 10/28/2024 – Centene was downgraded by analysts at StockNews.com from a “strong-buy” rating to a “buy” rating.
• 10/25/2024 – Centene had its price target lowered by analysts at Robert W. Baird from $83.00 to $66.00. They now have a “neutral” rating on the stock.
• 10/15/2024 – Centene was upgraded by analysts at StockNews.com from a “buy” rating to a “strong-buy” rating.
• 10/7/2024 – Centene was downgraded by analysts at StockNews.com from a “strong-buy” rating to a “buy” rating.
• 10/1/2024 – Centene had its “overweight” rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $90.00 price target on the stock.
• 9/20/2024 – Centene had its “overweight” rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $90.00 price target on the stock.

Centene Stock Down 1.0 %

Shares of Centene stock traded down $0.56 during trading on Wednesday, reaching $58.04. The company’s stock had a trading volume of 6,850,071 shares, compared to its average volume of 3,969,779. The company has a quick ratio of 1.10, a current ratio of 1.10 and a debt-to-equity ratio of 0.64. The company has a market cap of $29.30 billion, a price-to-earnings ratio of 10.08, a P/E/G ratio of 0.80 and a beta of 0.49. Centene Co. has a 1-year low of $57.56 and a 1-year high of $81.42. The company has a 50-day simple moving average of $68.91 and a two-hundred day simple moving average of $71.30.

Insiders Place Their Bets

In other news, CEO Sarah London purchased 4,117 shares of the stock in a transaction on Friday, November 8th. The stock was bought at an average price of $60.80 per share, with a total value of $250,313.60. Following the transaction, the chief executive officer now owns 667,229 shares in the company, valued at $40,567,523.20. The trade was a 0.00 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.33% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Centene

Institutional investors have recently modified their holdings of the stock. Park Place Capital Corp raised its stake in shares of Centene by 1,190.0% during the 3rd quarter. Park Place Capital Corp now owns 387 shares of the company’s stock valued at $29,000 after buying an additional 357 shares during the last quarter. WR Wealth Planners LLC raised its stake in shares of Centene by 41.4% during the 2nd quarter. WR Wealth Planners LLC now owns 468 shares of the company’s stock valued at $31,000 after buying an additional 137 shares during the last quarter. Chris Bulman Inc purchased a new position in shares of Centene during the 2nd quarter valued at about $33,000. Riverview Trust Co raised its stake in shares of Centene by 154.6% during the 2nd quarter. Riverview Trust Co now owns 527 shares of the company’s stock valued at $35,000 after buying an additional 320 shares during the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. purchased a new position in shares of Centene during the 2nd quarter valued at about $36,000. Hedge funds and other institutional investors own 93.63% of the company’s stock.

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.